Sort
21,453 grants matching “tuberculosis”
RECOMBINANT BCG MALARIA VACCINES
$531,893Yeshiva University · R01 · FY2001 · AI
Administrative Core
$531,864Paul Edward Farmer · Brigham And Women'S Hospital · U19 · FY2008 · AI
Mtb strain-dependent mechanisms of pathogenesis in mouse models
$531,862Kevin B Urdahl · University Of Washington · U19 · FY2022 · AI
Protein/Lipid Interactions
$531,714Robert B. Gennis · University Of Illinois At Urbana-Champaign · R01 · FY2015 · HL
Resue of CF phagocyte function with CFTR modulator therapy
$531,709Benjamin T Kopp · Emory University · R01 · FY2023 · HL
Stimulating Protective CD4+ T Cell Immunity to Chlamydia trachomatis (Starnbach)
$531,660Michael N Starnbach · University Of New Mexico Health Scis Ctr · U19 · FY2014 · AI
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 2/2)
$531,617Gabriel Chamie · University Of California, San Francisco · U01 · FY2018 · AA
Inhibitors of protein-protein interactions
$531,607Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
SOC Core
$531,487Aleksandar Milosavljevic · Baylor College Of Medicine · U54 · FY2018 · DA
Treatment Options for Protease Inhibitor Exposed Children
$531,284Louise Kuhn · Columbia University Health Sciences · R01 · FY2010 · HD
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa
$531,253Jason V Baker · Hennepin Healthcare Research Institute · R01 · FY2022 · HL
Columbia-South Africa Training Program for Research on HIV-associated Malignanci
$531,157Alfred I Neugut · Columbia University Health Sciences · D43 · FY2010 · CA
A "radical" approach to tuberculosis infection
$531,000Deborah T Hung · Broad Institute, Inc. · R33 · FY2015 · AI
A "radical" approach to tuberculosis infection
$531,000Deborah T Hung · Broad Institute, Inc. · R33 · FY2016 · AI
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa
$530,979Jason V Baker · Hennepin Healthcare Research Institute · R01 · FY2023 · HL
Antibacterial Host Defense
$530,943Robert Munford · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
NOVEL MECHANISM OF INNATE DEFENSE IN MURINE TB
$530,850Boston University Medical Campus · R01 · FY2000 · HL
Project 1: Innate immune responses triggered by Listeria monocytogenes
$530,768Daniel A Portnoy · University Of California Berkeley · P01 · FY2020 · AI
Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infections
$530,571Grace C John-Stewart · University Of Washington · R01 · FY2014 · HD
Analysis of Host-Pathogen Interactions
$530,487Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
VOLATILE MARKERS OF PULMONARY TUBERCULOSIS IN THE BREATH
$530,310Michael Phillips · Menssana Research, Inc. · R44 · FY2006 · AI
VOLATILE MARKERS OF PULMONARY TUBERCULOSIS IN THE BREATH
$530,310Menssana Research, Inc. · R44 · FY2005 · AI
RNA modification and antibiotic resistance
$530,163Graeme L Conn · Emory University · R01 · FY2023 · AI
Initiation of the Immune Response to M. tuberculosis
$530,161Joel D. Ernst · New York University School Of Medicine · R01 · FY2010 · AI
Building Tuberculosis Clinical Research Capacity in China
$530,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA